• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素II 2型受体在心血管系统研究中的最新进展。

Recent progress in angiotensin II type 2 receptor research in the cardiovascular system.

作者信息

Horiuchi M, Akishita M, Dzau V J

机构信息

Division of Cardiovascular Research, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

出版信息

Hypertension. 1999 Feb;33(2):613-21. doi: 10.1161/01.hyp.33.2.613.

DOI:10.1161/01.hyp.33.2.613
PMID:10024316
Abstract

Angiotensin II (Ang II) plays an important role in regulating cardiovascular hemodynamics and structure. Multiple lines of evidence have suggested the existence of Ang II receptor subtypes, and at least 2 distinct receptor subtypes have been defined on the basis of their differential pharmacological and biochemical properties and designated as type 1 (AT1) and type 2 (AT2) receptors. To date, most of the known effects of Ang II in adult tissues are attributable to the AT1 receptor. Recent cloning of the AT2 receptor contributes to reveal its physiological functions, but many functions of the AT2 receptor are still an enigma. AT1 and AT2 receptors belong to the 7-transmembrane, G protein-coupled receptor family. However, accumulating evidence demonstrates that the function and signaling mechanisms of these receptor subtypes are quite different, and these receptors may exert opposite effects in terms of cell growth and blood pressure regulation. We will review the role of the AT2 receptor in the cardiovascular system and the molecular and cellular mechanisms of AT2 receptor action.

摘要

血管紧张素II(Ang II)在调节心血管血流动力学和结构方面发挥着重要作用。多条证据表明存在Ang II受体亚型,并且根据其不同的药理和生化特性至少定义了2种不同的受体亚型,分别命名为1型(AT1)和2型(AT2)受体。迄今为止,Ang II在成体组织中的大多数已知作用都归因于AT1受体。AT2受体的近期克隆有助于揭示其生理功能,但AT2受体的许多功能仍是一个谜。AT1和AT2受体属于7跨膜G蛋白偶联受体家族。然而,越来越多的证据表明这些受体亚型的功能和信号传导机制有很大不同,并且这些受体在细胞生长和血压调节方面可能发挥相反的作用。我们将综述AT2受体在心血管系统中的作用以及AT2受体作用的分子和细胞机制。

相似文献

1
Recent progress in angiotensin II type 2 receptor research in the cardiovascular system.血管紧张素II 2型受体在心血管系统研究中的最新进展。
Hypertension. 1999 Feb;33(2):613-21. doi: 10.1161/01.hyp.33.2.613.
2
[Pathophysiological roles of angiotensin in the pathogenesis of hypertension and cardiovascular remodeling].
Rinsho Byori. 2000 Oct;48(10):935-40.
3
Cross talk between angiotensin II type 1 and type 2 receptors: cellular mechanism of angiotensin type 2 receptor-mediated cell growth inhibition.血管紧张素II 1型和2型受体之间的相互作用:血管紧张素2型受体介导的细胞生长抑制的细胞机制
Hypertens Res. 1999 Jul;22(2):67-74. doi: 10.1291/hypres.22.67.
4
Molecular biology of angiotensin receptors: target for drug research?血管紧张素受体的分子生物学:药物研究的靶点?
J Hypertens Suppl. 1994 Jul;12(2):S1-5.
5
[Recent progress in AT1 and AT2 receptor research].
Nihon Rinsho. 2002 Oct;60(10):1873-80.
6
Physiological and pharmacological implications of AT1 versus AT2 receptors.
Kidney Int Suppl. 1998 Sep;67:S95-9. doi: 10.1046/j.1523-1755.1998.06719.x.
7
[The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].[血管紧张素II受体选择性阻断在心血管疾病治疗中的作用]
Clin Ter. 2001 Mar-Apr;152(2):103-6.
8
Extrarenal aspects of angiotensin II function.
Eur J Endocrinol. 1997 Apr;136(4):349-58. doi: 10.1530/eje.0.1360349.
9
[Angiotensin II receptor].[血管紧张素 II 受体]
Nihon Rinsho. 2004 Jan;62(1):29-36.
10
[Pathophysiological function of angiotensin II AT1 and AT2 receptors and clinical application of AT1 antagonists].[血管紧张素 II AT1 和 AT2 受体的病理生理功能及 AT1 拮抗剂的临床应用]
Nihon Rinsho. 1998 Jul;56(7):1912-8.

引用本文的文献

1
ATIP1 Is a Suppressor of Cardiac Hypertrophy and Modulates AT2-Dependent Signaling in Cardiac Myocytes.ATIP1是心肌肥厚的抑制因子,并调节心肌细胞中依赖于AT2的信号传导。
Cells. 2025 Apr 28;14(9):645. doi: 10.3390/cells14090645.
2
An emerging view on vascular fibrosis molecular mediators and relevant disorders: from bench to bed.血管纤维化分子介质及相关疾病的新观点:从实验台到临床
Front Cardiovasc Med. 2023 Dec 21;10:1273502. doi: 10.3389/fcvm.2023.1273502. eCollection 2023.
3
Comparison of Outcomes Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Myocardial Infarction: A Meta-Analysis.
心肌梗死患者中血管紧张素转换酶抑制剂与血管紧张素II受体阻滞剂疗效的比较:一项荟萃分析
Cureus. 2023 Oct 30;15(10):e47954. doi: 10.7759/cureus.47954. eCollection 2023 Oct.
4
Aromatase enzyme: Paving the way for exploring aromatization for cardio-renal protection.芳香化酶:探索芳香化作用以保护心肾的途径。
Biomed Pharmacother. 2023 Dec;168:115832. doi: 10.1016/j.biopha.2023.115832. Epub 2023 Nov 6.
5
ACE2, ACE, DPPIV, PREP and CAT L enzymatic activities in COVID-19: imbalance of ACE2/ACE ratio and potential RAAS dysregulation in severe cases.COVID-19 中的 ACE2、ACE、DPPIV、PREP 和 CAT L 酶活性:严重病例中 ACE2/ACE 比值失衡和潜在的 RAAS 失调。
Inflamm Res. 2023 Aug;72(8):1719-1731. doi: 10.1007/s00011-023-01775-3. Epub 2023 Aug 3.
6
The AT/AT Receptor Equilibrium Is a Cornerstone of the Regulation of the Renin Angiotensin System beyond the Cardiovascular System.血管紧张素原/血管紧张素受体平衡是肾素-血管紧张素系统调节的基石,不仅局限于心血管系统。
Molecules. 2023 Jul 18;28(14):5481. doi: 10.3390/molecules28145481.
7
Prospects of Novel and Repurposed Immunomodulatory Drugs against Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19 Disease.新型及重新利用的免疫调节药物治疗与2019冠状病毒病相关的急性呼吸窘迫综合征(ARDS)的前景
J Pers Med. 2023 Apr 13;13(4):664. doi: 10.3390/jpm13040664.
8
Critical roles of cytokine storm and bacterial infection in patients with COVID-19: therapeutic potential of mesenchymal stem cells.细胞因子风暴和细菌感染在 COVID-19 患者中的关键作用:间充质干细胞的治疗潜力。
Inflammopharmacology. 2023 Feb;31(1):171-206. doi: 10.1007/s10787-022-01132-6. Epub 2023 Jan 4.
9
Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic.高血压的代偿性肾素-血管紧张素系统:COVID-19 大流行时代的回顾与更新。
Biochem Pharmacol. 2023 Feb;208:115370. doi: 10.1016/j.bcp.2022.115370. Epub 2022 Dec 5.
10
AT2 activation does not influence brain damage in the early phase after experimental traumatic brain injury in male mice.AT2 激活不会影响雄性小鼠实验性颅脑损伤后早期的脑损伤。
Sci Rep. 2022 Aug 22;12(1):14280. doi: 10.1038/s41598-022-18338-x.